Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | Europe (Supplemental) | 2023

The European open surgery instrument market was negatively impacted by the COVID-19 pandemic. However, the overall market for open surgery instruments will exhibit modest growth over the forecast period. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium-priced products, although rising laparoscopic procedure penetration—and consequently declining open procedure volumes—will hamper market expansion.

This Medtech 360 Report provides high-level market metrics for open surgery instruments in Europe, including country-level data for major countries and aggregate data for the rest of Europe, from 2019 through 2031.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…